José Antonio Garrido (ICREA @ ICN2) and Carolina Aguilar are the entrepreneurs of the biotech InBrain Neuroelectronics , a spin-off company established in 2019 and based in Barcelona. The investment was led by Imec.xpand, Belgian venture capital fund specialised in semiconductors and nanotechnology.
InBrain technology was successfully used for the first time ever in a human patient undergoing surgical resection of a gliomal tumour. InBrain sensors were able to distinguish malingnat cells from healthy tissue to guide the scalpel of the resection with unprecedented precision.
See below a couple of press releases, and click here to go to ICN2 website and find out more about the science behind this breakthrough.
Biocat
The New Barcelona Post
OTHER NEWS
5 ICREAs amongst the 1% most cited researchers of 2024 worldwide
Congratulations to all of them, and also to their host institutions for this well deserved recognition. · Josep Dalmau (FRCB-IDIBAPS)…
ERC Synergy grants 2024
Congratulations to Diego Blas, Mariona Graupera and Kostas Kostarelos on their recent success in one of the most prestigious of…